Medtronic (MDT) Total Current Liabilities (2014 - 2026)
Medtronic (MDT) reported Total Current Liabilities of $11.7 billion for Q2 2026, down 9.48% on a YoY basis from $12.9 billion in Q2 2025, and up 22.78% sequentially from $9.5 billion in Q1 2026.
Medtronic (MDT) Total Current Liabilities (2014 - 2026) Analysis & Trends
Medtronic (MDT) has 13 years of Total Current Liabilities data on file, last reported at $11.7 billion in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 9.48% year-over-year to $11.7 billion; the trailing twelve-month figure through Apr 2026 stood at $11.7 billion (down 9.48% YoY), and the FY2026 full-year result was $11.7 billion, down 9.48% from the prior year.
- Total Current Liabilities advanced to $11.7 billion in Q2 2026, from $9.5 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $14.5 billion in Q4 2022 to a low of $8.9 billion in Q1 2022.
- A 5-year average of $11.2 billion and a median of $11.2 billion in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 85.38% in 2022 and sank 35.6% in 2023, its largest moves.
- Tracing MDT's Total Current Liabilities over 5 years: stood at $14.5 billion in 2022, then sank by 33.23% to $9.7 billion in 2023, then climbed by 26.26% to $12.2 billion in 2024, then declined by 18.53% to $9.9 billion in 2025, then increased by 17.34% to $11.7 billion in 2026.
- Business Quant data shows MDT's Total Current Liabilities at $11.7 billion in Q2 2026, $9.5 billion in Q1 2026, and $9.9 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 11.66 Bn |
| Jan 23, 2026 | 9.50 Bn |
| Oct 24, 2025 | 9.94 Bn |
| Jul 25, 2025 | 11.53 Bn |
| Apr 25, 2025 | 12.88 Bn |
| Jan 24, 2025 | 11.84 Bn |
| Oct 25, 2024 | 12.20 Bn |
| Jul 26, 2024 | 10.29 Bn |
| Apr 26, 2024 | 10.79 Bn |
| Jan 26, 2024 | 9.79 Bn |
| Oct 27, 2023 | 9.66 Bn |
| Jul 28, 2023 | 9.05 Bn |
| Apr 28, 2023 | 9.05 Bn |
| Jan 27, 2023 | 14.42 Bn |
| Oct 28, 2022 | 14.47 Bn |
| Jul 29, 2022 | 14.05 Bn |
| Apr 29, 2022 | 12.39 Bn |
| Jan 28, 2022 | 8.93 Bn |
| Oct 29, 2021 | 7.80 Bn |
| Jul 30, 2021 | 7.76 Bn |